CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106. A total of 36 filers reported holding CONSTELLATION PHARMCETICLS I in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $391,000 | +200.8% | 17,141 | +261.1% | 0.00% | – |
| Q4 2020 | $130,000 | +319.4% | 4,747 | +233.6% | 0.00% | – |
| Q3 2020 | $31,000 | -50.8% | 1,423 | -34.3% | 0.00% | – |
| Q2 2020 | $63,000 | +6200.0% | 2,165 | +11927.8% | 0.00% | – |
| Q1 2020 | $1,000 | -98.9% | 18 | -99.1% | 0.00% | – |
| Q4 2019 | $91,000 | +911.1% | 1,937 | +43.0% | 0.00% | – |
| Q3 2019 | $9,000 | -43.8% | 1,355 | +4.1% | 0.00% | – |
| Q2 2019 | $16,000 | -59.0% | 1,302 | -54.3% | 0.00% | – |
| Q1 2019 | $39,000 | +254.5% | 2,850 | -3.5% | 0.00% | – |
| Q4 2018 | $11,000 | -42.1% | 2,952 | +2.5% | 0.00% | – |
| Q3 2018 | $19,000 | – | 2,880 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ponoi II Management, LLC | 1,574,229 | $36,821,000 | 28.20% |
| Ponoi Management, LLC | 1,880,623 | $43,988,000 | 25.87% |
| VR Adviser, LLC | 4,016,873 | $93,955,000 | 10.19% |
| Column Group LLC | 2,626,631 | $61,437,000 | 5.89% |
| Euclidean Capital LLC | 554,325 | $12,966,000 | 4.34% |
| GREAT POINT PARTNERS LLC | 872,415 | $20,406,000 | 4.22% |
| Venrock Management V, LLC | 1,570,058 | $36,724,000 | 3.76% |
| COMMODORE CAPITAL LP | 368,448 | $8,618,000 | 3.43% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 621,541 | $14,538,000 | 1.90% |
| Bain Capital Life Sciences Investors, LLC | 1,400,000 | $32,746,000 | 1.86% |